A Low or High Physical Activity Level Does Not Modulate Prostate Tumor Tissue Protein Synthesis Rates
Lisanne H P Houben, Tom Tuytten1, Andrew M Holwerda2
1Department of Urology, Jessa Hospital, Hasselt, BELGIUM.
Medicine and Science in Sports and Exercise
|December 11, 2023
Summary
Short-term high or low physical activity levels do not affect protein synthesis in prostate cancer patients. Further research is needed to understand physical activity
Area of Science:
- Oncology
- Metabolism
- Exercise Physiology
Background:
- Physical activity influences cancer development and progression.
- Prostate cancer patients' protein synthesis rates were examined in relation to physical activity.
Purpose of the Study:
- To determine the impact of low versus high physical activity on protein synthesis in skeletal muscle, healthy prostate, and prostate tumor tissue in vivo.
- To investigate the short-term effects of physical activity levels on prostate cancer metabolism.
Main Methods:
- Thirty prostate cancer patients were randomized into low (<4000 steps/day) or high (>14,000 steps/day) activity groups for 7 days before surgery.
- Deuterium oxide was administered, and tissue samples were collected during radical prostatectomy to measure protein synthesis rates.
Main Results:
- No significant differences in protein synthesis rates were found in skeletal muscle, healthy prostate, or prostate tumor tissue between the low and high activity groups.
- Prostate tumor tissue exhibited nearly twofold higher protein synthesis rates compared to non-tumorous prostate tissue.
Conclusions:
- Short-term high or low physical activity levels do not alter in vivo protein synthesis rates in prostate or prostate tumor tissue in prostate cancer patients.
- Further investigation is warranted to understand the influence of physical activity on tumor protein synthesis and progression, informing potential lifestyle interventions for cancer prevention and treatment.
Related Concept Videos
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Overview of Protein Metabolism
1.2K
Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
1.2K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
The Proteasome
8.7K
Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
8.7K


